secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001193125-23-058263
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio files Delaware court petition to validate share increase amendments after Boxed ruling
--------------------------------------------------------------------------------

- Filed petition in Delaware Court of Chancery under Section 205 of DGCL to validate charter amendment increasing authorized shares of Class A from 500M to 1B and Class B from 20M to 60M.
- Petition follows December 2022 Boxed ruling that created uncertainty about whether separate class votes were required for share increases by SPACs.
- Hearing set for March 14, 2023; company warns failure to validate could materially impact ability to timely file 2022 Form 10-K.
- Company states that majority of all common stock voted in favor, and that Class A holders actually provided majority support even without separate vote.
- If validation is not granted, uncertainty could affect validity of shares issued since February 2021 and ongoing operational matters like ESPP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523058263/0001193125-23-058263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312523058263/d477803d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-058263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer